• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.36 número1

Has 10000 "Rev. Bras. Hematol. Hemoter. vol.36 número1" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.36 número1".

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... 8. Rodrigues MC, Hamerschlak N, Moraes DA, Simões BP, Rodrigues M, Ribeiro AA, Voltarelli JC. Guidelines of the Brazilian Society of Bone Marrow Transplantation on hematopoietic stem cell transplantation as a treatment ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Considering that changes in local bacterial epidemiology can impact treatment effectiveness and patient safety, this study assessed whether there was emergence of quinolone resistance[r] ... See full document

8

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Patients submitted to hematopoietic stem cell transplants and those in the conditioning period of acute myeloid leukemia chemotherapy are at the highest risk of developing long and se[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Steensma DP, Hanson CA, Tefferi A, Independent validation of the 2008 World Health Organization (WHO) reclassification of myelodysplastic syndromes (MDS) associated with ring siderobl[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... This report describes a 43-year-old patient who, after allogeneic bone marrow transplantation, developed an oral squamous cell carcinoma secondary to the use of azathioprine, cyclospor[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... The present study presents an overview on important aspects of this immunological crosstalk, particularly on the abnormalities of chronic lymphocytic leukemia B-cells and the alteratio[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Extraordinary scientific progress made in the field of chronic myeloid leukemia (CML) led to the development of orally available tyrosine kinase inhibitors (TKIs), dramatically improv[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Three hundred and nine (55%) individuals positive for HTLV were male. The ages ranged from 18 to 65 years; 305 (54%) were aged 40 years or older (Table 2). It was also observed that 259 (46%) were single and 204 ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Lichenoid lesions are considered a diagnostic feature by the NIH criteria, and were observed in all patients that presented oral features within one year post-HCT; many patients prese[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... reported that single nucleotide polymorphisms (SNPs) located within the promoter region and exon 1 of the MBL2 gene are correlated with MBL protein serum levels and, consequently, a[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... 17. Castro TG, Novaes JF, Silva R, Costa NM, Franceschini SC, Tinôco AL, et al. Caracterização do consumo alimentar. ambiente socioeconômico e estado nutricional de pré- escolares de creches municipais. Rev Nutr. ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX r[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... The following variables were investigated: year, number of live births, total screening, coverage ratio, prevalence, time between the child birth and the blood collection; age at diagn[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... 4. Galvão-Castro B, Lourdes L, Rodrigues LG, Sereno A, Ferreira Júnior OC, Franco LG, et al. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion. ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... Histopathologic diagnosis of chronic graft- versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-hos[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... 1. Holanda K, Lucena-Araujo AR, Quintas A, Mendonça T, Lima A, Vasconcelos LR, et al. Mannose-binding lectin 2 (MBL2) gene polymorphisms do not influence frequency of infection in chronic lymphocytic leukemia patients. ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... describe a method using fluorescence reticulocyte intensity (low [LFR], medium [MFR], and high [HFR] fluorescence reticulocyte indexes) instead of RMI in order to improve the characte[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... a 36-year-old woman with a previous his- tory of diabetes mellitus and ischemic cardiomyopathy had complaints of persistent anemia, fatigue and weight loss (17 pounds in six ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... Nevertheless, the alterations contained in the new regulations (ANVISA Resolution RDC 57/2010 and MoH Ordinance 2712/2013) were minimal with regard to screening donors for malaria in end[r] ... See full document

9

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... In this case, despite the medical staff having asserted that the patient was not undergoing curative therapy, the parents denied the unfavorable progression of the disease and did not ac[r] ... See full document

6

Show all 10000 documents...